Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
05/2011
05/26/2011WO2011061330A2 Use of physiological cooling active ingredients, and agents containing such active ingredients
05/26/2011WO2011002927A3 Polymers comprising at least one bithiophene repeat unit, methods synthetising said polymers and compositions comprising the same
05/26/2011US20110124675 The hydrosulfate of prasugrel, its pharmaceutical combination and use thereof
05/26/2011US20110124674 5/5-or 5/6-membered condensed ring cycloalkylamine derivative
05/26/2011US20110124642 Potassium channel modulators
05/26/2011US20110124636 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
05/26/2011US20110124633 Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy
05/25/2011EP2325187A1 The hydrosulfate of prasugrel, its pharmaceutical combination and uses thereof
05/25/2011EP2324020A2 Piperidine derivatives as jak3 inhibitors
05/25/2011EP2324006A2 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
05/25/2011EP1317454B1 Caspase inhibitors and uses thereof
05/25/2011CN1832938B N-heterocyclyl phenyl-substituted cyclic ketoenols
05/25/2011CN1578663B Inhibitors of histone deacetylase
05/25/2011CN102076699A Hydrogensulfate salt of 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation
05/25/2011CN102076687A Substituted quinazolines as blood platelet lowering agents
05/25/2011CN102076685A Substituted quinazolines
05/25/2011CN102076667A Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
05/25/2011CN102070649A Synthesis method of aryl thiophthene derivative
05/25/2011CN102070648A Preparation method of clopidogrel hydrogen sulfate I
05/25/2011CN102070603A Method for synthesizing polysubstituted [b]-thionaphthene derivatives
05/25/2011CN101429205B Process for producing 3,4-enedioxy thiophene
05/25/2011CN101027308B Photochromic monomers, photochromic polymers based on the same, photochromic recording media comprising the photochromic polymers, and 3D read/write optical memory comprising the recording media
05/24/2011US7947691 Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof
05/24/2011US7947690 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example
05/24/2011CA2393710C Caspase inhibitors and uses thereof
05/19/2011WO2011060217A1 Spiropiperidine compounds as orl-1 receptor antagonists
05/19/2011WO2011060035A1 Spiropiperidine compounds as orl-1 receptor antagonists
05/19/2011WO2011059042A1 Aromatic ring compound
05/19/2011WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers
05/19/2011WO2011058149A1 Tricyclic pyrazol amine derivatives
05/19/2011WO2011058110A1 Quinoline and quinoxaline derivatives as kinase inhibitors
05/19/2011WO2011057593A2 New salts of prasugrel and a method of their production
05/19/2011WO2011057592A1 Method of producing highly pure prasugrel and pharmaceutically acceptable salts thereof
05/19/2011US20110118470 Nitrogen-containing aromatic derivatives
05/19/2011US20110118467 Process for the preparation of clopidogrel hydrogen sulfate crystalline form i
05/19/2011US20110118303 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
05/19/2011US20110118301 Amino-Aza-Adamantane Derivatives and Methods of Use
05/19/2011US20110118284 Thienopyrimidine compounds
05/19/2011US20110118278 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
05/19/2011US20110118251 Spiropiperidine compounds as orl-1 receptor antagonists
05/19/2011US20110118230 Diazacarbazoles and methods of use
05/19/2011US20110118136 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
05/19/2011CA2796161A1 Spiropiperidine compounds as orl-1 receptor antagonists
05/19/2011CA2781041A1 Spiropiperidine compounds as orl-1 receptor antagonists
05/19/2011CA2780547A1 Spiro-oxindole mdm2 antagonists
05/19/2011CA2778174A1 Tricyclic pyrazol amine derivatives
05/18/2011EP2322524A1 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/18/2011EP2321303A2 Compounds that modulate intracellular calcium
05/18/2011EP2321282A1 New benzimidazole derivatives
05/18/2011EP2320906A1 Heterocyclic amide derivatives as ep4 receptor antagonists
05/18/2011EP0971914B1 NEUTRAL COLOURING PHOTOCHROMIC 2H-NAPHTHO 1,2-b PYRANS AND HETEROCYCLIC PYRANS
05/18/2011CN101469000B Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer
05/18/2011CN101381371B Dithiolopyrrolones compounds and preparation method and application thereof
05/18/2011CN101348491B Phenyl ethylene end capped tetrathiophen derivative, preparation and use thereof
05/18/2011CN101186611B Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application
05/18/2011CN101175749B Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
05/18/2011CN101087794B Pharmaceutical compounds
05/17/2011US7943800 Migrastatin analogs and uses thereof
05/17/2011US7943769 Fluorinated derivative of quinolin-2(1H)-one, method for preparing the same and use thereof as a synthesis intermediate
05/17/2011US7943639 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss
05/17/2011US7943617 Heterobicyclic compounds useful as kinase inhibitors
05/12/2011WO2011055378A1 Improved process for preparation of clopiodogrel bisulfate crystalline form-1
05/12/2011WO2011055115A1 Akt / pkb inhibitors
05/12/2011WO2011054844A1 Condensed azepine derivatives as bromodomain inhibitors
05/12/2011US20110112088 Pyrazoles for the treatment of obesity and other cns disorders
05/12/2011US20110112086 Pyridinone analogs
05/12/2011US20110112072 Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof
05/12/2011US20110111514 Labelling reagents having a pyridine nucleus bearing a diazomethyl function, process for synthesis of such reagents and processes for detection of biological molecules
05/11/2011EP2319848A1 2,2'-Di (3,4-alkylenedioxythiophene) derivatives and their use for the preparation of 2,2'-Poly-(3,4-alkylendioxythiophene)-Derivatives
05/11/2011EP2318391A1 Tricyclic heterocycle derivatives as histamine h3 antagonists
05/11/2011EP1606254B1 2,4,6-phenyl substituted cyclic ketoenols
05/11/2011CN102056931A Method for preparing clopidogrel and its derivatives
05/11/2011CN102056911A Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound
05/11/2011CN102056899A Polycyclic compound and organic electroluminescent device using the same
05/11/2011CN102050829A Crystallizing method for obtaining I crystal form (+)-(S)-clopidogrel bisulfate
05/11/2011CN102050828A Prasugrel salt and preparation method thereof
05/11/2011CN101463038B Production method of (-)-(R)- clopidogrel (-)-(R)-camphorsulfonate racemisation
05/11/2011CN101412726B Novel heterocyclic compounds
05/10/2011US7939533 Dual NK1/NK3 receptor antagonists
05/10/2011CA2436935C Serine protease inhibitors
05/05/2011WO2011052940A2 Process for preparing clopidogrel hydrogensulfate form i
05/05/2011WO2011052759A1 Novel nitroxyl radical compound and process for production thereof
05/05/2011WO2011052728A1 Compound and element using same
05/05/2011WO2011052727A1 Compound and element using same
05/05/2011WO2011052702A1 Polymeric compound and electronic element
05/05/2011WO2011052500A1 Wax stable formulation
05/05/2011WO2011051976A2 An improved process for the preparation of clopidogrel bisulfate form i
05/05/2011WO2011051478A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
05/05/2011WO2011051212A1 Use of heteroaromatic compounds as herbicides
05/05/2011WO2010151737A3 Heterocyclic compounds and their uses as inhibitors of pi3 k activity
05/05/2011US20110105490 2,3-dihydro-1h-isoindol-1-imine derivatives useful as thrombin par-1 receptor antagonist
05/05/2011US20110104109 Tetracyclic indole derivatives and their use for treating or preventing viral infections
05/05/2011US20110102973 Stabilised thiophene derivatives
05/05/2011US20110102970 Monomers of selected colour numbers and capacitors prepared therefrom
05/05/2011DE102010042866A1 New thioamide compounds, useful for controlling undesirable plant growth or weeds in cultural plants e.g. Arachis hypogaea, Allium cepa, Elaeis guineensis and Gossypium herbaceum
05/05/2011CA2779073A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
05/04/2011EP2316834A1 Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase
05/04/2011EP2315768A1 Thieno-pyridine derivatives as mek inhibitors
05/04/2011EP2315755A2 SYNTHESIS OF DIHYDROTHIENO[3,2-d]PYRIMIDINE DIOLS AND SIMILAR PYRIMIDINE DIOLS
05/04/2011EP2315751A1 Alkynyl alcohols as kinase inhibitors
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 214